Blandine Lehmann

1.5k total citations
9 papers, 257 citations indexed

About

Blandine Lehmann is a scholar working on Epidemiology, Genetics and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Blandine Lehmann has authored 9 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Genetics and 2 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Blandine Lehmann's work include Intensive Care Unit Cognitive Disorders (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Blandine Lehmann is often cited by papers focused on Intensive Care Unit Cognitive Disorders (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Blandine Lehmann collaborates with scholars based in France, Switzerland and United States. Blandine Lehmann's co-authors include Roselyne Boulieu, Sylvie Chevret, Éliane Gluckman, Catherine Cordonnier, M Legrand, Annick Tibi, D. Pradeau, Djillali Annane, Dominique Morlet and F Salord and has published in prestigious journals such as Annals of Internal Medicine, Intensive Care Medicine and British Journal of Clinical Pharmacology.

In The Last Decade

Blandine Lehmann

9 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blandine Lehmann France	8	57	52	42	36	32	9	257
Evelyn Jones United States	10	53 0.9×	27 0.5×	77 1.8×	19 0.5×	73 2.3×	10	418
Anil Pareek India	12	16 0.3×	27 0.5×	32 0.8×	28 0.8×	16 0.5×	29	443
Antonella Cotoia Italy	13	9 0.2×	55 1.1×	38 0.9×	14 0.4×	43 1.3×	43	378
David Case United States	13	10 0.2×	53 1.0×	23 0.5×	9 0.3×	9 0.3×	39	460
Eva‐Luise Hobl Austria	13	49 0.9×	22 0.4×	17 0.4×	10 0.3×	14 0.4×	21	532
Carter D. Brooks United States	14	24 0.4×	23 0.4×	36 0.9×	3 0.1×	8 0.3×	27	457
Eva María Sáez Fernández Spain	7	11 0.2×	38 0.7×	14 0.3×	10 0.3×	11 0.3×	11	345
Tushar Shukla Canada	7	10 0.2×	145 2.8×	34 0.8×	9 0.3×	19 0.6×	16	535
Paola Mian Netherlands	13	7 0.1×	37 0.7×	30 0.7×	5 0.1×	46 1.4×	50	460
Denise L. Howrie United States	14	89 1.6×	31 0.6×	28 0.7×	26 0.7×	13 0.4×	26	425

Countries citing papers authored by Blandine Lehmann

Since Specialization

Citations

This map shows the geographic impact of Blandine Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blandine Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blandine Lehmann more than expected).

Fields of papers citing papers by Blandine Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blandine Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blandine Lehmann. The network helps show where Blandine Lehmann may publish in the future.

Co-authorship network of co-authors of Blandine Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Blandine Lehmann. A scholar is included among the top collaborators of Blandine Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blandine Lehmann. Blandine Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Berlin, Ivan, et al.. (2019). Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol. BMJ Open. 9(5). e028832–e028832. 13 indexed citations

Annane, Djillali, Alain Cariou, Claude Martin, et al.. (2016). Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial. Annals of Intensive Care. 6(1). 43–43. 13 indexed citations

Annane, Djillali, et al.. (2011). Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic. Intensive Care Medicine. 38(1). 29–39. 26 indexed citations

Abbara, Chadi, B. Estournet, Lucette Lacomblez, et al.. (2010). Riluzole pharmacokinetics in young patients with spinal muscular atrophy. British Journal of Clinical Pharmacology. 71(3). 403–410. 20 indexed citations

Cordonnier, Catherine, et al.. (2003). Should Immunoglobulin Therapy Be Used in Allogeneic Stem-Cell Transplantation?. Annals of Internal Medicine. 3 indexed citations

Cordonnier, Catherine, et al.. (2003). Should Immunoglobulin Therapy Be Used in Allogeneic Stem-Cell Transplantation?. Annals of Internal Medicine. 139(1). 8–18. 77 indexed citations

Boulieu, Roselyne, et al.. (1998). Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients. European Journal of Drug Metabolism and Pharmacokinetics. 23(2). 255–258. 26 indexed citations

Lehmann, Blandine, et al.. (1998). Determination of total cysteamine in human serum by a high-performance liquid chromatography with fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 17(4-5). 767–773. 40 indexed citations

Lehmann, Blandine & Roselyne Boulieu. (1995). Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 674(1). 138–142. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact